Ledesma, Baby Girl .
HRN: 27-22-83 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/02/2025
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
06/02/2025
06/09/2025
IVTT
27 Mg
Q24hr
Sepsis
Waiting Final Action
Indication: Empiric Type of Infection: Bloodstream Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes